vs
华美银行集团（EWBC）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是华美银行集团的1.9倍（$1.5B vs $775.0M），华美银行集团净利率更高（46.2% vs 12.9%，领先33.3%），Steris同比增速更快（9.2% vs 2.1%），过去两年华美银行集团的营收复合增速更高（18.4% vs 15.8%）
华美银行集团旗下核心子公司为华美银行，是总部位于美国南加州的最大上市银行控股集团。集团资产规模超100亿美元，曾获评标普全球市场财智全美最佳银行，自2023年起连续三年位列《银行董事》杂志同资产规模银行绩效榜单首位。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
EWBC vs STE — 直观对比
营收规模更大
STE
是对方的1.9倍
$775.0M
营收增速更快
STE
高出7.1%
2.1%
净利率更高
EWBC
高出33.3%
12.9%
两年增速更快
EWBC
近两年复合增速
15.8%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $775.0M | $1.5B |
| 净利润 | $358.0M | $192.9M |
| 毛利率 | — | 43.8% |
| 营业利润率 | — | 18.3% |
| 净利率 | 46.2% | 12.9% |
| 营收同比 | 2.1% | 9.2% |
| 净利润同比 | 0.4% | 11.2% |
| 每股收益（稀释后） | $2.57 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWBCSTE
| Q1 26 | $775.0M | — | ||
| Q4 25 | $657.8M | $1.5B | ||
| Q3 25 | $677.5M | $1.5B | ||
| Q2 25 | $617.1M | $1.4B | ||
| Q1 25 | $600.2M | $1.5B | ||
| Q4 24 | $587.6M | $1.4B | ||
| Q3 24 | $572.7M | $1.3B | ||
| Q2 24 | $553.2M | $1.3B |
净利润EWBCSTE
| Q1 26 | $358.0M | — | ||
| Q4 25 | $356.3M | $192.9M | ||
| Q3 25 | $368.4M | $191.9M | ||
| Q2 25 | $310.3M | $177.4M | ||
| Q1 25 | $290.3M | $145.7M | ||
| Q4 24 | $293.1M | $173.5M | ||
| Q3 24 | $299.2M | $150.0M | ||
| Q2 24 | $288.2M | $145.4M |
毛利率EWBCSTE
| Q1 26 | — | — | ||
| Q4 25 | — | 43.8% | ||
| Q3 25 | — | 44.2% | ||
| Q2 25 | — | 45.1% | ||
| Q1 25 | — | 43.3% | ||
| Q4 24 | — | 44.5% | ||
| Q3 24 | — | 43.6% | ||
| Q2 24 | — | 44.7% |
营业利润率EWBCSTE
| Q1 26 | — | — | ||
| Q4 25 | 71.0% | 18.3% | ||
| Q3 25 | 68.6% | 18.2% | ||
| Q2 25 | 65.2% | 17.7% | ||
| Q1 25 | 65.2% | 14.6% | ||
| Q4 24 | 60.6% | 17.9% | ||
| Q3 24 | 68.0% | 16.5% | ||
| Q2 24 | 65.9% | 14.5% |
净利率EWBCSTE
| Q1 26 | 46.2% | — | ||
| Q4 25 | 54.2% | 12.9% | ||
| Q3 25 | 54.4% | 13.1% | ||
| Q2 25 | 50.3% | 12.8% | ||
| Q1 25 | 48.4% | 9.8% | ||
| Q4 24 | 49.9% | 12.7% | ||
| Q3 24 | 52.2% | 11.3% | ||
| Q2 24 | 52.1% | 11.4% |
每股收益（稀释后）EWBCSTE
| Q1 26 | $2.57 | — | ||
| Q4 25 | $2.55 | $1.96 | ||
| Q3 25 | $2.65 | $1.94 | ||
| Q2 25 | $2.24 | $1.79 | ||
| Q1 25 | $2.08 | $1.48 | ||
| Q4 24 | $2.10 | $1.75 | ||
| Q3 24 | $2.14 | $1.51 | ||
| Q2 24 | $2.06 | $1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $423.7M |
| 总债务越低越好 | — | $1.9B |
| 股东权益账面价值 | $9.0B | $7.2B |
| 总资产 | $82.9B | $10.6B |
| 负债/权益比越低杠杆越低 | — | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资EWBCSTE
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $423.7M | ||
| Q3 25 | $4.7B | $319.2M | ||
| Q2 25 | $4.4B | $279.7M | ||
| Q1 25 | $3.4B | $171.7M | ||
| Q4 24 | $5.3B | $155.2M | ||
| Q3 24 | $4.9B | $172.2M | ||
| Q2 24 | $4.4B | $198.3M |
总债务EWBCSTE
| Q1 26 | — | — | ||
| Q4 25 | $35.6M | $1.9B | ||
| Q3 25 | $35.7M | $1.9B | ||
| Q2 25 | $35.8M | $1.9B | ||
| Q1 25 | $35.9M | $1.9B | ||
| Q4 24 | $36.0M | $2.0B | ||
| Q3 24 | $36.1M | $2.2B | ||
| Q2 24 | $36.1M | $2.2B |
股东权益EWBCSTE
| Q1 26 | $9.0B | — | ||
| Q4 25 | $8.9B | $7.2B | ||
| Q3 25 | $8.6B | $7.0B | ||
| Q2 25 | $8.2B | $7.0B | ||
| Q1 25 | $7.9B | $6.6B | ||
| Q4 24 | $7.7B | $6.4B | ||
| Q3 24 | $7.7B | $6.6B | ||
| Q2 24 | $7.2B | $6.4B |
总资产EWBCSTE
| Q1 26 | $82.9B | — | ||
| Q4 25 | $80.4B | $10.6B | ||
| Q3 25 | $79.7B | $10.4B | ||
| Q2 25 | $78.2B | $10.4B | ||
| Q1 25 | $76.2B | $10.1B | ||
| Q4 24 | $76.0B | $10.0B | ||
| Q3 24 | $74.5B | $10.2B | ||
| Q2 24 | $72.5B | $10.1B |
负债/权益比EWBCSTE
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | 0.27× | ||
| Q3 25 | 0.00× | 0.27× | ||
| Q2 25 | 0.00× | 0.27× | ||
| Q1 25 | 0.00× | 0.29× | ||
| Q4 24 | 0.00× | 0.32× | ||
| Q3 24 | 0.00× | 0.33× | ||
| Q2 24 | 0.01× | 0.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $298.2M |
| 自由现金流经营现金流 - 资本支出 | — | $199.5M |
| 自由现金流率自由现金流/营收 | — | 13.3% |
| 资本支出强度资本支出/营收 | — | 6.6% |
| 现金转化率经营现金流/净利润 | — | 1.55× |
| 过去12个月自由现金流最近4个季度 | — | $917.1M |
8季度趋势，按日历期对齐
经营现金流EWBCSTE
| Q1 26 | — | — | ||
| Q4 25 | $713.4M | $298.2M | ||
| Q3 25 | $231.7M | $287.8M | ||
| Q2 25 | $278.7M | $420.0M | ||
| Q1 25 | $277.9M | $260.8M | ||
| Q4 24 | $500.1M | $332.8M | ||
| Q3 24 | $386.1M | $250.7M | ||
| Q2 24 | $259.2M | $303.7M |
自由现金流EWBCSTE
| Q1 26 | — | — | ||
| Q4 25 | — | $199.5M | ||
| Q3 25 | — | $201.3M | ||
| Q2 25 | — | $326.4M | ||
| Q1 25 | — | $189.9M | ||
| Q4 24 | — | $243.6M | ||
| Q3 24 | — | $148.8M | ||
| Q2 24 | — | $195.7M |
自由现金流率EWBCSTE
| Q1 26 | — | — | ||
| Q4 25 | — | 13.3% | ||
| Q3 25 | — | 13.8% | ||
| Q2 25 | — | 23.5% | ||
| Q1 25 | — | 12.8% | ||
| Q4 24 | — | 17.8% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 15.3% |
资本支出强度EWBCSTE
| Q1 26 | — | — | ||
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | — | 6.7% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | — | 8.4% |
现金转化率EWBCSTE
| Q1 26 | — | — | ||
| Q4 25 | 2.00× | 1.55× | ||
| Q3 25 | 0.63× | 1.50× | ||
| Q2 25 | 0.90× | 2.37× | ||
| Q1 25 | 0.96× | 1.79× | ||
| Q4 24 | 1.71× | 1.92× | ||
| Q3 24 | 1.29× | 1.67× | ||
| Q2 24 | 0.90× | 2.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EWBC
暂无分部数据
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
